Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Op-Ed: Prices for New Drugs Are Rising 20 Percent a Year. Congress Needs to Act
HOME
/
Commentary & Opinion
/
Op-Ed: Prices for New Drugs Are Rising 20 Percent a Year. Congress Needs to Act